Capital Research Global Investors Novo Nordisk A S Transaction History

Capital Research Global Investors

$440 Billion
Q1 2025

A detailed history of Capital Research Global Investors transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Research Global Investors holds 57,530 shares of NVO stock, worth $3.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,530

Previous 48,250 19.23%

Holding current value

$3.7 Million

Previous $4.15 Million 3.76%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$69.3 - $90.95 $643,104 - $844,016	9,280 Added 19.23%	57,530 $3.99 Million
Q4 2024 Feb 13, 2025	SELL	$85.0 - $120.04 $564,060 - $796,585	-6,636 Reduced 12.09%	48,250 $4.15 Million
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $555,937 - $678,965	4,669 Added 9.3%	54,886 $6.54 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $366,166 - $438,379	2,984 Added 6.32%	50,217 $7.17 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $1.35 Million - $1.79 Million	13,181 Added 38.71%	47,233 $6.06 Million
Q4 2023 Feb 13, 2024	BUY	$87.78 - $105.45 $35,726 - $42,918	407 Added 1.21%	34,052 $3.52 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.58 Million - $3.47 Million	17,378 Added 106.83%	33,645 $3.06 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $39,462 - $43,680	253 Added 1.58%	16,267 $2.63 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $808,862 - $972,663	-6,112 Reduced 27.62%	16,014 $2.55 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $2.27 Million - $2.99 Million	22,126 New	22,126 $2.99 Million
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $514 - $563	-11 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $44 - $50	-1 Reduced 8.33%	11 $1,000
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $339 - $406	7 Added 140.0%	12 $1,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $205 - $246	5	5 $0

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

329M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $145B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Novo Nordisk A S Transaction History